Biocon Ltd. Quarterly balance sheet by MarketWatch. View all BIOCON assets, cash, debt, liabilities, shareholder equity and investments.
Biocon Ltd expects an annualised benefit of around ₹300 crore in FY27 from reduced interest costs as it completes the exit of structured equity investors Goldman Sachs, Kotak, and Edelweiss, Siddharth ...
TipRanks on MSN
Biocon shareholders clear capital expansion, preferential issue and higher investment limits at EGM
Biocon Limited ( ($IN:BIOCON) ) just unveiled an update. Biocon Limited reported the results of its Extraordinary General Meeting held on 31 ...
Biocon Share Price: Solid earnings, robust biosimilars growth, and improving margins drive renewed optimism; analysts see double-digit upside potential in the stock. Biocon share price Biocon shares ...
Biocon Limited’s board on December 6 approved a plan to fully integrate Biocon Biologics Limited (BBL) into the parent company and to raise fresh capital to fund the cash portion of the deal. The ...
MUMBAI: Weight-loss and diabetes drugs such as semaglutide and liraglutide are expected to drive near-term growth in Biocon Ltd’s generics business, chief executive and managing director Siddharth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback